A vaccine trains your immune system to recognize and fight a specific germ before you ever get sick from it. It does this by introducing something harmless that looks like the real threat, whether that’s a weakened version of a virus, a piece of its outer shell, or genetic instructions for your cells to build that piece themselves. Your body mounts a defense, learns from the experience, and stores that knowledge for years or even decades. If the real pathogen shows up later, your immune system already knows exactly what to do.
How Your Immune System Responds
When a vaccine enters your body, your immune system treats it like an actual invader. Immune cells at the injection site detect unfamiliar proteins on the vaccine’s surface and sound the alarm. White blood cells rush to the area, engulf the foreign material, and break it into fragments. Those fragments get displayed on the surface of specialized cells, essentially holding up a “wanted poster” for the rest of the immune system.
This kicks off a two-pronged response. One branch produces antibodies, Y-shaped proteins that latch onto the invader and neutralize it. The other branch activates cells that hunt down and destroy any of your own cells that have been infected. Both of these responses are critical: antibodies handle threats floating freely in your blood and tissues, while killer cells clean up infections that have already gotten inside your cells.
The most important part happens after the threat is gone. A small fraction of the immune cells involved don’t die off. Instead, they become memory cells, long-lived sentinels that circulate through your body for years. These memory cells are the whole point of vaccination. If you encounter the real pathogen months or years later, they recognize it almost instantly and trigger a faster, stronger response than your body could mount on its own the first time. This is why vaccinated people often fight off infections before symptoms even develop.
How Long Protection Lasts
The typical half-life of vaccine-induced immune memory in humans is 8 to 15 years. That doesn’t mean protection vanishes at year 8. It means the population of memory cells and the antibodies they help produce gradually decline over time. Some vaccines, like the one for measles, provide protection that lasts decades with just two doses. Others, like tetanus, need a booster roughly every 10 years to keep antibody levels high enough to be protective.
Memory cells aren’t static. They’re a dynamic population in constant turnover, dividing and replacing themselves even without re-exposure to the pathogen. Early after vaccination, these cells replace themselves roughly every 100 days. Later, turnover slows to about once a year, which helps explain why protection persists so long. For some vaccines, though, antibody levels drop faster in older adults, which is one reason boosters become more important with age. Studies on COVID-19 vaccines found that in younger adults, spike-targeting antibodies had a half-life of over 200 days, but older adults often needed a booster dose to reach comparable antibody levels.
Why Vaccines Cause Side Effects
That sore arm, mild fever, or day of fatigue after a shot isn’t a sign something went wrong. It’s your innate immune system doing exactly what it’s supposed to do. When immune cells at the injection site detect the vaccine, they release signaling molecules that trigger inflammation: redness, swelling, and pain at the spot where the needle went in. Some of those signals enter the bloodstream and reach the brain, which can produce fever, muscle aches, and tiredness.
These symptoms typically peak within 24 to 48 hours and resolve on their own. They’re a compressed, milder version of what happens during a real infection. Not everyone experiences them, and their absence doesn’t mean the vaccine didn’t work. Your adaptive immune system, the branch that builds lasting memory, operates more quietly behind the scenes.
Different Vaccine Types, Same Goal
Not all vaccines deliver their payload the same way, but every type aims to show your immune system what a pathogen looks like without causing disease.
- Live-attenuated vaccines use a weakened form of the actual virus or bacterium. Because the germ can still replicate a little, these vaccines tend to produce strong, long-lasting immunity, often with just one or two doses. The measles, mumps, and rubella (MMR) vaccine works this way.
- Inactivated vaccines use a killed version of the germ. They’re stable and safe but generally produce a weaker immune response, so they often require multiple doses or boosters. Flu shots and the polio shot are examples.
- Protein subunit vaccines skip the whole germ entirely and deliver just a key protein from the pathogen’s surface. Your immune cells pick up these proteins, recognize them as foreign, and build a response. These vaccines often include an adjuvant, an added ingredient that amplifies the immune reaction.
- mRNA vaccines take a different approach. Instead of delivering the protein directly, they deliver genetic instructions that tell your own cells to build a harmless piece of the target protein. Your cells manufacture it, display it on their surface, and the immune system responds. The mRNA itself is broken down and cleared from the body within days.
It Takes a Few Weeks to Work
Protection doesn’t kick in the moment the needle goes in. Your immune system needs time to recognize the vaccine’s contents, activate the right cells, produce antibodies, and generate memory. This process generally takes a few weeks. During that window, you’re still vulnerable to infection, which is why timing matters: getting a flu shot in September gives your body time to build immunity before peak flu season.
Vaccines that require two or more doses are designed this way for a reason. The first dose introduces the antigen and primes the immune system. The second dose, given weeks or months later, triggers a much stronger “recall” response. Memory cells generated after the first dose spring into action, producing more antibodies at higher levels than the first round. This booster effect is why completing a full vaccine series matters more than just getting a single shot.
How Vaccines Protect Communities
Vaccines don’t just protect the person who gets the shot. When enough people in a community are immune to a disease, the pathogen has fewer hosts to infect and struggles to spread. This is herd immunity, and it shields people who can’t be vaccinated themselves, including newborns, people undergoing chemotherapy, and those with compromised immune systems.
The threshold for herd immunity depends on how contagious the disease is. Measles spreads so easily that about 95% of a population needs to be vaccinated to keep it in check. For polio, the threshold is lower, around 80%. When vaccination rates dip below these levels, outbreaks follow quickly, as communities in several countries have seen with measles in recent years.
Globally, about 89% of infants received at least one dose of a basic combination vaccine in 2024, reaching roughly 115 million children. But 14.3 million infants, referred to as “zero-dose” children, didn’t receive a single vaccine dose that year. These gaps in coverage leave entire regions vulnerable to diseases that are otherwise preventable.
How Vaccine Safety Is Tracked
Before any vaccine reaches the public, it goes through a multi-phase clinical trial process that tests it in progressively larger groups of people. But monitoring doesn’t stop once a vaccine is approved. In the United States, the CDC operates multiple overlapping surveillance systems to catch problems that might not appear in clinical trials.
One system collects reports from anyone, healthcare providers or the public, about health problems that occur after vaccination. Another tracks large patient databases from healthcare organizations to compare rates of specific conditions in vaccinated versus unvaccinated people. A third allowed individuals who received COVID-19 vaccines to log symptoms through their phones in real time. These systems work in parallel so that rare side effects, even those affecting one in a million people, can be detected and investigated after a vaccine is widely distributed.